Expression Regulation and Functional Analysis of RGS2 and RGS4 in Adipogenic and Osteogenic Differentiation of Human Mesenchymal Stem Cells

Overview

Journal Biol Res

Specialty Biology

Date 2017 Dec 28

PMID 29279050

Citations 9

Authors

Alma Madrigal

Lun Tan

Yuanxiang Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Understanding the molecular basis underlying the formation of bone-forming osteocytes and lipid-storing adipocytes will help provide insights into the cause of disorders originating in stem/progenitor cells and develop therapeutic treatments for bone- or adipose-related diseases. In this study, the role of RGS2 and RGS4, two members of the regulators of G protein signaling (RGS) family, was investigated during adipogenenic and osteogenenic differentiation of human mesenchymal stem cells (hMSCs).

Results: Expression of RGS2 and RGS4 were found to be inversely regulated during adipogenesis induced by dexamethasone (DEX) and 3-isobutyl-methylxanthine, regardless if insulin was present, with RGS2 up-regulated and RGS4 down-regulated in response to adipogenic induction. RGS2 expression was also up-regulated during osteogenesis at a level similar to that induced by treatment of DEX alone, a shared component of adipogenic and osteogenic differentiation inducing media, but significantly lower than the level induced by adipogenic inducing media. RGS4 expression was down-regulated during the first 48 h of osteogenesis but up-regulated afterwards, in both cases at levels similar to that induced by DEX alone. Expression knock-down using small interfering RNA against RGS2 resulted in decreased differentiation efficiency during both adipogenesis and osteogenesis. On the other hand, expression knock-down of RGS4 also resulted in decreased adipogenic differentiation but increased osteogenic differentiation.

Conclusions: RGS2 and RGS4 are differentially regulated during adipogenic and osteogenic differentiation of hMSCs. In addition, both RGS2 and RGS4 play positive roles during adipogenesis but opposing roles during osteogenesis, with RGS2 as a positive regulator and RGS4 as a negative regulator. These results imply that members of RGS proteins may play multifaceted roles during human adipogenesis and osteogenesis to balance or counterbalance each other's function during those processes.

Citing Articles

Single-cell RNA sequencing uncovers heterogenous immune cell responses upon exposure to food additive (E171) titanium dioxide.

Perumalsamy H, Xiao X, Han H, Oh J, Yoon S, Heo M J Nanobiotechnology. 2024; 22(1):765.

PMID: 39696498 PMC: 11657454. DOI: 10.1186/s12951-024-03036-9.

Melatonin ameliorates inflammation-induced developmental defects of enamel by upregulating regulator of G protein signaling 2.

Bi M, Zhou Y, Yang X, Li Y, Ren Q, Pan J J Dent Sci. 2024; 19(4):2355-2366.

PMID: 39347090 PMC: 11437336. DOI: 10.1016/j.jds.2024.01.019.

Hsa-miR-874-3p Reduces Endogenous Expression of RGS4-1 Isoform In Vitro.

Xu F, Wang B Genes (Basel). 2024; 15(8).

PMID: 39202417 PMC: 11353307. DOI: 10.3390/genes15081057.

Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure.

Yan W, Lin X, Ying Y, Li J, Fan Z Int J Oral Sci. 2023; 15(1):6.

PMID: 36631441 PMC: 9834262. DOI: 10.1038/s41368-022-00202-3.

Effect of Regulator of G Protein Signaling Proteins on Bone.

Yuan G, Yang S Front Endocrinol (Lausanne). 2022; 13:842421.

PMID: 35573989 PMC: 9098968. DOI: 10.3389/fendo.2022.842421.

References

Freytag S, Paielli D, Gilbert J . Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 1994; 8(14):1654-63. DOI: 10.1101/gad.8.14.1654. View

Kroeze W, Sheffler D, Roth B . G-protein-coupled receptors at a glance. J Cell Sci. 2003; 116(Pt 24):4867-9. DOI: 10.1242/jcs.00902. View

Huang C, Geng J, Jiang S . MicroRNAs in regulation of osteogenic differentiation of mesenchymal stem cells. Cell Tissue Res. 2016; 368(2):229-238. DOI: 10.1007/s00441-016-2462-2. View

Ong W, Sugii S . Adipose-derived stem cells: fatty potentials for therapy. Int J Biochem Cell Biol. 2013; 45(6):1083-6. DOI: 10.1016/j.biocel.2013.02.013. View

Siddappa R, Fernandes H, Liu J, van Blitterswijk C, de Boer J . The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering. Curr Stem Cell Res Ther. 2008; 2(3):209-20. DOI: 10.2174/157488807781696267. View

Zhang J, Chen J . Bone Tissue Regeneration - Application of Mesenchymal Stem Cells and Cellular and Molecular Mechanisms. Curr Stem Cell Res Ther. 2016; 12(5):357-364. DOI: 10.2174/1574888X11666160921121555. View

Zhang Y, Khan D, Delling J, Tobiasch E . Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal. 2012; 2012:793823. PMC: 3317548. DOI: 10.1100/2012/793823. View

de Sousa Abreu R, Penalva L, Marcotte E, Vogel C . Global signatures of protein and mRNA expression levels. Mol Biosyst. 2009; 5(12):1512-26. PMC: 4089977. DOI: 10.1039/b908315d. View

Martin J, Zielenska M, Stein G, van Wijnen A, Squire J . The Role of RUNX2 in Osteosarcoma Oncogenesis. Sarcoma. 2011; 2011:282745. PMC: 3005824. DOI: 10.1155/2011/282745. View

10.

Fei Y, Hurley M . Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation. J Cell Physiol. 2012; 227(11):3539-45. PMC: 3371283. DOI: 10.1002/jcp.24075. View

11.

Deng W, Wang X, Xiao J, Chen K, Zhou H, Shen D . Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance. PLoS One. 2012; 7(1):e30256. PMC: 3260252. DOI: 10.1371/journal.pone.0030256. View

12.

NISHIZUKA M, Honda K, Tsuchiya T, Nishihara T, Imagawa M . RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma. J Biol Chem. 2001; 276(32):29625-7. DOI: 10.1074/jbc.C100272200. View

13.

Huang W, Yang S, Shao J, Li Y . Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci. 2007; 12:3068-92. PMC: 3571113. DOI: 10.2741/2296. View

14.

Hollinger S, Hepler J . Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev. 2002; 54(3):527-59. DOI: 10.1124/pr.54.3.527. View

15.

Wilkie T . G-protein signaling: satisfying the basic necessities of life. Curr Biol. 2000; 10(23):R853-6. DOI: 10.1016/s0960-9822(00)00823-x. View

16.

Bethel M, Chitteti B, Srour E, Kacena M . The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis. Curr Osteoporos Rep. 2013; 11(2):99-106. PMC: 3643998. DOI: 10.1007/s11914-013-0135-6. View

17.

Vogel C, Marcotte E . Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012; 13(4):227-32. PMC: 3654667. DOI: 10.1038/nrg3185. View

18.

Tontonoz P, Hu E, Spiegelman B . Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994; 79(7):1147-56. DOI: 10.1016/0092-8674(94)90006-x. View

19.

Lowe C, ORahilly S, Rochford J . Adipogenesis at a glance. J Cell Sci. 2011; 124(Pt 16):2681-6. DOI: 10.1242/jcs.079699. View

20.

Nobusue H, Onishi N, Shimizu T, Sugihara E, Oki Y, Sumikawa Y . Regulation of MKL1 via actin cytoskeleton dynamics drives adipocyte differentiation. Nat Commun. 2014; 5:3368. DOI: 10.1038/ncomms4368. View